NCT05206838 Achilles Tendon for the Treatment of Gluteus Medius Insufficiency
| NCT ID | NCT05206838 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sahlgrenska University Hospital |
| Condition | Arthroplasty Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2022-06-29 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2022-06-29 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Residual limping after total hip arthroplasty is a serious complication that lacks effective treatment. The purpose of this study is to evaluate a surgical treatment for residual limping and compare its results with non-surgical treatment. Our hypothesis is that surgical treatment followed by physiotherapy increases hip function and reduces limping compared with non-surgical treatment with physiotherapy alone.
Eligibility Criteria
Inclusion Criteria: * Persisting limping with positive Trendelenburg's sign for at least 12 months after total hip arthroplasty * Rupture/avulsion of the gluteus medius tendon verified with ultrasound or MRI * Leg length discrepancy of less than 1 cm * Femoral offset discrepancy of less than 25% Exclusion Criteria: * Neuromuscular disorders
Contact & Investigator
Georgios Tsikandylakis, MD, PhD
PRINCIPAL INVESTIGATOR
Sahlgrenska University Hospital
Frequently Asked Questions
Who can join the NCT05206838 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Arthroplasty Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05206838 currently recruiting?
Yes, NCT05206838 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sahlgrenska University Hospital to inquire about joining.
Where is the NCT05206838 trial being conducted?
This trial is being conducted at Mölndal, Sweden.
Who is sponsoring the NCT05206838 clinical trial?
NCT05206838 is sponsored by Sahlgrenska University Hospital. The principal investigator is Georgios Tsikandylakis, MD, PhD at Sahlgrenska University Hospital. The trial plans to enroll 44 participants.